Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.

Jeyapalan JN, Doctor GT, Jones TA, Alberman SN, Tep A, Haria CM, Schwalbe EC, Morley IC, Hill AA, LeCain M, Ottaviani D, Clifford SC, Qaddoumi I, Tatevossian RG, Ellison DW, Sheer D.

Acta Neuropathol Commun. 2016 May 27;4(1):54. doi: 10.1186/s40478-016-0323-6.

2.

Legius Syndrome: two novel mutations in the SPRED1 gene.

Bianchi M, Saletti V, Micheli R, Esposito S, Molinaro A, Gagliardi S, Orcesi S, Cereda C.

Hum Genome Var. 2015 Dec 3;2:15051. doi: 10.1038/hgv.2015.51. eCollection 2015.

3.

Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia.

Ito T, Itakura J, Takahashi S, Sato M, Mino M, Fushimi S, Yamada M, Morishima T, Kunkel SL, Matsukawa A.

Crit Care Med. 2016 Jul;44(7):e530-43. doi: 10.1097/CCM.0000000000001562.

PMID:
26757161
4.

Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.

Hirata Y, Brems H, Suzuki M, Kanamori M, Okada M, Morita R, Llano-Rivas I, Ose T, Messiaen L, Legius E, Yoshimura A.

J Biol Chem. 2016 Feb 12;291(7):3124-34. doi: 10.1074/jbc.M115.703710. Epub 2015 Dec 3.

PMID:
26635368
5.

Concomitant BET and MAPK blockade for effective treatment of ovarian cancer.

Jing Y, Zhang Z, Ma P, An S, Shen Y, Zhu L, Zhuang G.

Oncotarget. 2016 Jan 19;7(3):2545-54. doi: 10.18632/oncotarget.6309.

6.

Mechanisms of FGF gradient formation during embryogenesis.

Balasubramanian R, Zhang X.

Semin Cell Dev Biol. 2016 May;53:94-100. doi: 10.1016/j.semcdb.2015.10.004. Epub 2015 Oct 8. Review.

PMID:
26454099
8.

Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation.

Satpathy S, Wagner SA, Beli P, Gupta R, Kristiansen TA, Malinova D, Francavilla C, Tolar P, Bishop GA, Hostager BS, Choudhary C.

Mol Syst Biol. 2015 Jun 2;11(6):810. doi: 10.15252/msb.20145880.

9.

MicroRNA-132/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway.

Lei Z, van Mil A, Brandt MM, Grundmann S, Hoefer I, Smits M, El Azzouzi H, Fukao T, Cheng C, Doevendans PA, Sluijter JP.

J Cell Mol Med. 2015 Aug;19(8):1994-2005. doi: 10.1111/jcmm.12586. Epub 2015 May 6.

10.

Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells.

Yang Y, Liu X, Xiao F, Xue S, Xu Q, Yin Y, Sun H, Xu J, Wang H, Zhang Q, Wang H, Wang L.

PLoS One. 2015 Feb 17;10(2):e0117573. doi: 10.1371/journal.pone.0117573. eCollection 2015.

11.

Spred-2 deficiency exacerbates lipopolysaccharide-induced acute lung inflammation in mice.

Xu Y, Ito T, Fushimi S, Takahashi S, Itakura J, Kimura R, Sato M, Mino M, Yoshimura A, Matsukawa A.

PLoS One. 2014 Oct 2;9(9):e108914. doi: 10.1371/journal.pone.0108914. eCollection 2014.

12.

MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1.

Sharma SB, Lin CC, Farrugia MK, McLaughlin SL, Ellis EJ, Brundage KM, Salkeni MA, Ruppert JM.

Mol Cell Biol. 2014 Nov 15;34(22):4143-64. doi: 10.1128/MCB.00480-14. Epub 2014 Sep 8.

13.

The MAPK pathway as an apoptosis enhancer in melanoma.

Haydn JM, Hufnagel A, Grimm J, Maurus K, Schartl M, Meierjohann S.

Oncotarget. 2014 Jul 15;5(13):5040-53.

14.

The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease.

Butland SL, Sanders SS, Schmidt ME, Riechers SP, Lin DT, Martin DD, Vaid K, Graham RK, Singaraja RR, Wanker EE, Conibear E, Hayden MR.

Hum Mol Genet. 2014 Aug 1;23(15):4142-60. doi: 10.1093/hmg/ddu137. Epub 2014 Apr 4.

15.

Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer.

Liu D, Yang C, Bojdani E, Murugan AK, Xing M.

J Natl Cancer Inst. 2013 Nov 6;105(21):1617-27. doi: 10.1093/jnci/djt249. Epub 2013 Oct 17.

16.

ERK and phosphoinositide 3-kinase temporally coordinate different modes of actin-based motility during embryonic wound healing.

Li J, Zhang S, Soto X, Woolner S, Amaya E.

J Cell Sci. 2013 Nov 1;126(Pt 21):5005-17. doi: 10.1242/jcs.133421. Epub 2013 Aug 28.

17.

The RASopathies.

Rauen KA.

Annu Rev Genomics Hum Genet. 2013;14:355-69. doi: 10.1146/annurev-genom-091212-153523. Epub 2013 Jul 15. Review.

18.

Dynamic recruitment of microRNAs to their mRNA targets in the regenerating liver.

Schug J, McKenna LB, Walton G, Hand N, Mukherjee S, Essuman K, Shi Z, Gao Y, Markley K, Nakagawa M, Kameswaran V, Vourekas A, Friedman JR, Kaestner KH, Greenbaum LE.

BMC Genomics. 2013 Apr 18;14:264. doi: 10.1186/1471-2164-14-264.

19.
20.

Modeling cognitive dysfunction in neurofibromatosis-1.

Diggs-Andrews KA, Gutmann DH.

Trends Neurosci. 2013 Apr;36(4):237-47. doi: 10.1016/j.tins.2012.12.002. Epub 2013 Jan 8. Review.

Items per page

Supplemental Content

Write to the Help Desk